Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Hyukjoon Choi"'
Publikováno v:
Microorganisms, Vol 11, Iss 7, p 1718 (2023)
This study explored the potential of Lactococcus lactis subsp. lactis CAB701 as a probiotic strain, focusing on its immunostimulatory properties. Despite adverse conditions in the gastrointestinal environment, this strain exhibited remarkable surviva
Externí odkaz:
https://doaj.org/article/1f63ff07914b4da7af56f73c9cdc0bc3
Publikováno v:
Microorganisms; Volume 11; Issue 7; Pages: 1718
This study explored the potential of Lactococcus lactis subsp. lactis CAB701 as a probiotic strain, focusing on its immunostimulatory properties. Despite adverse conditions in the gastrointestinal environment, this strain exhibited remarkable surviva
Publikováno v:
New Physics: Sae Mulli. 71:737-746
Autor:
Seong-Min Hwang, Hyukjoon Choi
Publikováno v:
Institute of Brain-based Education, Korea National University of Education. 10:499-509
Publikováno v:
Institute of Brain-based Education, Korea National University of Education. 10:431-442
Autor:
Youngwook Song, Hyukjoon Choi
Publikováno v:
The journal of Educational Studies. 51:91-109
Autor:
Jongmin Park, Hyukjoon Choi
Publikováno v:
Institute of Brain-based Education, Korea National University of Education. 9:307-318
Autor:
Hayoung Hwang, Hyukjoon Choi, Kyung-Hee Kim, Woo-Sik Kim, Hakdo Kim, Jayhyuk Myung, Geumwoo Lee, Kyungjin Jung, Wonken Choung, Jungwook Chin, Jeongmin Joo, Min Park, Seong Heon Kim, Su Min Jang, Jae Soo Lim, Tae-ho Jang, Eunmi Hong, Boram Lee, Deokmo Yang
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:2275-2282
As a potential treatment of type 2 diabetes, a novel PPARγ non-TZD full agonist, compound 18 (BR102375) was identified from the original lead BR101549 by the SAR efforts of the labile metabolite control through bioisosteres approach. In vitro assess
Autor:
Dong-Young Kim, Hyukjoon Choi
Publikováno v:
Research Institute of Education Science, Jeju National University. 21:1-21
Autor:
Kyung-Hee Kim, Geumwoo Lee, Jayhyuk Myung, Kyungjin Jung, Wonken Choung, Eun Hye Nam, Su Min Jang, Deokmo Yang, Min Park, Eunmi Hong, Seong Heon Kim, Boram Lee, Hyukjoon Choi, Jae Soo Lim, Hui Jin Jung, Woo-Sik Kim, Jungwook Chin, Tae-ho Jang
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:631-637
The new class of PPARgamma non-TZD agonist originally derived from the backbone of anti-hypertensive Fimasartan, BR101549, was identified as a potential lead for anti-diabetic drug development. The X-ray crystallography of BR101549 with PPARgamma lig